134 related articles for article (PubMed ID: 28914964)
1. Clinicopathological and molecular implications of aberrant thyroid transcription factor-1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones.
Bae JM; Kim JH; Park JH; Park HE; Cho NY; Kang GH
Histopathology; 2018 Feb; 72(3):423-432. PubMed ID: 28914964
[TBL] [Abstract][Full Text] [Related]
2. The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications.
Prabhakaran S; Woo WLW; Xing G; Moffat D; Hussey M; Henderson DW; Klebe S
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):471-476. PubMed ID: 31135446
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.
Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Mattsson JSM; Botling J; Micke P; Jönsson P; Brunnström H
Am J Clin Pathol; 2018 Oct; 150(6):533-544. PubMed ID: 30169783
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
Klebe S; Swalling A; Jonavicius L; Henderson DW
J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
[TBL] [Abstract][Full Text] [Related]
5. Re-evaluating TTF-1 immunohistochemistry in diffuse gliomas: Expression is clone-dependent and associated with tumor location.
Pratt D; Afsar N; Allgauer M; Fetsch P; Palisoc M; Pittaluga S; Quezado M
Clin Neuropathol; 2017; 36(6):263-271. PubMed ID: 28933335
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Utility of Thyroid Transcription Factor-1 in Ovarian Carcinoma and Its Relationship With Clinicopathologic Prognostic Parameters.
Hakim SA; Youssef NS
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):237-243. PubMed ID: 26657873
[TBL] [Abstract][Full Text] [Related]
7. Thyroid transcription factor-1 expression in colorectal adenocarcinomas.
Dettmer M; Kim TE; Jung CK; Jung ES; Lee KY; Kang CS
Pathol Res Pract; 2011 Nov; 207(11):686-90. PubMed ID: 22019009
[TBL] [Abstract][Full Text] [Related]
8. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.
Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S
Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215
[TBL] [Abstract][Full Text] [Related]
9. Aberrant TTF-1 Expression in Peripheral T-Cell Lymphomas: A Diagnostic Pitfall.
Chang ST; Chen SW; Chen BJ; Pan ST; Karube K; Chuang SS
Int J Surg Pathol; 2021 Apr; 29(2):165-168. PubMed ID: 32772757
[TBL] [Abstract][Full Text] [Related]
10. Different cutoff values for thyroid transcription factor-1 antibodies in the diagnosis of lung adenocarcinoma.
Smits AJ; Vink A; Tolenaars G; Herder GJ; Kummer JA
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):416-21. PubMed ID: 25356948
[TBL] [Abstract][Full Text] [Related]
11. Significant expression of thyroid transcription factor-1 in pulmonary squamous cell carcinoma detected by SPT24 monoclonal antibody and CSA-II system.
Kashima K; Hashimoto H; Nishida H; Arakane M; Yada N; Daa T; Yokoyama S
Appl Immunohistochem Mol Morphol; 2014; 22(2):119-24. PubMed ID: 23531851
[TBL] [Abstract][Full Text] [Related]
12. Thyroid transcription factor-1 promotes lymph node metastasis by inducing lymphangiogenesis in ovarian carcinoma.
Li M; Zheng W; Wei J; Hou C; Yang Y; Sun L; Wang C
Pathol Res Pract; 2017 Sep; 213(9):1054-1058. PubMed ID: 28843751
[TBL] [Abstract][Full Text] [Related]
13. Expression of CDX2 and Thyroid Transcription Factor-1 in Oropharyngeal Undifferentiated Carcinomas: A Potential Diagnostic Pitfall.
Chernock RD; Bibbey S; El-Mofty SK; Carpenter DH; Lewis JS
Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):268-273. PubMed ID: 27389559
[TBL] [Abstract][Full Text] [Related]
14. TTF-1 expression in breast carcinoma: an unusual but real phenomenon.
Ni YB; Tsang JY; Shao MM; Chan SK; Tong J; To KF; Tse GM
Histopathology; 2014 Mar; 64(4):504-11. PubMed ID: 24111789
[TBL] [Abstract][Full Text] [Related]
15. Thyroid transcription factor-1 in primary CNS tumors.
Kristensen MH; Nielsen S; Vyberg M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):437-43. PubMed ID: 21325940
[TBL] [Abstract][Full Text] [Related]
16. Unusual expression of thyroid transcription factor 1 and napsin A in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
An J; Park S; Sung SH; Cho MS; Kim SC
Am J Clin Pathol; 2014 May; 141(5):712-7. PubMed ID: 24713744
[TBL] [Abstract][Full Text] [Related]
17. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
18. Expression of thyroid transcription factor-1 in colorectal carcinoma.
Xu B; Thong N; Tan D; Khoury T
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):244-9. PubMed ID: 20042854
[TBL] [Abstract][Full Text] [Related]
19. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
[TBL] [Abstract][Full Text] [Related]
20. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors.
Matoso A; Singh K; Jacob R; Greaves WO; Tavares R; Noble L; Resnick MB; Delellis RA; Wang LJ
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):142-9. PubMed ID: 19887917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]